Copyright
©The Author(s) 2023.
World J Clin Oncol. Jun 24, 2023; 14(6): 227-229
Published online Jun 24, 2023. doi: 10.5306/wjco.v14.i6.227
Published online Jun 24, 2023. doi: 10.5306/wjco.v14.i6.227
Figure 1 Corrected “Figure 3”.
A-D: Kaplan-Meier curves representing post-liver transplant overall survival and recurrence-free survival in patients with intrahepatic cholangiocarcinoma (ICC) compared with patients with hepatocellular carcinoma (HCC), matched 1:8 for pretransplant tumor characteristics (A and B) and posttransplant tumor characteristics (C and D). HRs: Hazard ratios; CI: Confidence interval.
Figure 2 Corrected “Figure 4”.
A-D: Kaplan-Meier curves representing post-liver transplant overall survival and recurrence-free survival in patients with mixed hepatocellular-cholangiocarcinoma (HCC-CC) compared with patients with HCC, matched 1:8 for pretransplant tumor characteristics (A and B) and posttransplant tumor characteristics (C and D). HRs: Hazard ratios; CI: Confidence interval.
- Citation: Brandão ABM, Rodriguez S, Fleck Jr AM, Marroni CA, Wagner MB, Hörbe A, Fernandes MV, Cerski CT, Coral GP. Correction: Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant. World J Clin Oncol 2023; 14(6): 227-229
- URL: https://www.wjgnet.com/2218-4333/full/v14/i6/227.htm
- DOI: https://dx.doi.org/10.5306/wjco.v14.i6.227